secwatch.observer — SEC 8-K summary
======================================

Issuer:     InMed Pharmaceuticals Inc. (INM)
CIK:        0001728328
Form:       8-K
Filed at:   2022-08-11T23:59:59+00:00
Accession:  0001213900-22-046528
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

InMed appoints Nicole Lemerond to board; Adam Cutler resigns
------------------------------------------------------------

- Adam Cutler resigned from board effective Aug 8, 2022; no disagreement with the company.
- Nicole Lemerond appointed to board effective Aug 8, 2022; fills vacancy on Audit and Governance Committees.
- Ms. Lemerond has 25+ years in investment management, private equity, healthcare finance; CFA charterholder.
- Standard director compensation: $45,000 annual retainer plus options for 14,000 common shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1728328/000121390022046528/0001213900-22-046528-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1728328/000121390022046528/ea164185-8k_inmedphar.htm
  HTML page:      https://secwatch.observer/filing/0001213900-22-046528

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer